Back to Search Start Over

Exploring Post-treatment Weight Changes in Overweight and Obese Patients With Graves' Disease: A Retrospective Analysis.

Authors :
Guia Lopes ML
Bello C
Cidade JP
Cunha C
Limbert C
Sequeira Duarte J
Source :
Cureus [Cureus] 2024 Apr 30; Vol. 16 (4), pp. e59408. Date of Electronic Publication: 2024 Apr 30 (Print Publication: 2024).
Publication Year :
2024

Abstract

Introduction: Graves' disease (GD) is associated with primary hyperthyroidism, leading to weight loss before treatment. During the treatment, weight gain is frequently observed, often surpassing the initial weight loss. This study aimed to analyze weight fluctuations in GD patients, focusing on the subset of overweight and obese (OAO) individuals, considering the significant metabolic implications and heightened cardiovascular risk of these weight changes.<br />Methods: A retrospective cohort study included 122 GD patients with biochemical primary hyperthyroidism and at least 12 months of clinical follow-up after treatment for analysis. The OAO cohort comprised individuals with a body mass index (BMI) ≥25 kg/m². Data on laboratory, demographic, and weight variables were collected longitudinally.<br />Results: During the hyperthyroidism state, 34.4% (n=42) of patients presented with weight loss, a phenomenon linked to lower serum thyroid-stimulating hormone levels at diagnosis (p=0.010) and an extended need for anti-thyroid drug treatment (p<0.001). Following treatment, around 60% (n=73) of individuals encountered weight gain, exhibiting a higher prevalence among women (p<0.001) and those undergoing definitive treatment modalities (p=0.024). Notably, 26.2% (n=32) experienced excessive weight gain, which was correlated with higher premorbid BMI and diminished weight loss induced by hyperthyroidism (p<0.001). Within the OAO cohort, 66.7% (n=26) observed an increase in weight post-treatment, and in 28.2% (n=11), excessive weight gain was reported. Weight gain and excessive weight gain were noted in patients with higher initial BMIs.<br />Conclusions: This study highlights that post-treatment weight gain is common, emphasizing the need for careful weight management in GD. In OAO GD patients, the association between initial BMI and increased weight underscores potential cardiovascular risks, warranting vigilant monitoring and early intervention.<br />Competing Interests: The authors have declared that no competing interests exist.<br /> (Copyright © 2024, Guia Lopes et al.)

Details

Language :
English
ISSN :
2168-8184
Volume :
16
Issue :
4
Database :
MEDLINE
Journal :
Cureus
Publication Type :
Academic Journal
Accession number :
38826612
Full Text :
https://doi.org/10.7759/cureus.59408